Evidence map›Paper›PMID 27474443›Full record

ArticleGenes & development2016

A conserved virus-induced cytoplasmic TRAMP-like complex recruits the exosome to target viral RNA for degradation.

Jerome M Molleston, Leah R Sabin, Ryan H Moy, Sanjay V Menghani, Keiko Rausch, Beth Gordesky-Gold, Kaycie C Hopkins, Rui Zhou, Torben Heick Jensen, Jeremy E Wilusz and 1 more

Abstract read
In one paragraph

Article in Genes & development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Three Modes of Viral Adaption by the Heart.bioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jerome M MollestonDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Leah R SabinDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Ryan H MoyDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Sanjay V MenghaniDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Keiko RauschDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Beth Gordesky-GoldDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Kaycie C HopkinsDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Rui ZhouProgram for RNA Biology, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA;
Torben Heick JensenCentre for mRNP Biogenesis and Metabolism, Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark;
Jeremy E WiluszDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Sara CherryDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, JUDITH M. · 2003 to 2013
$91.5M
TRAINING IN VIROLOGYT32AI007324 · NIAID · WISTAR INSTITUTE · PI Paul Bates, Matthew D. Weitzman · 1989 to 2026
$6.8M
The role of autophagy in innate anti-viral immunity in DrosophilaR01AI074951 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2007 to 2017
$4.2M
Dissecting the alphavirus entry receptor NRAMPR01AI095500 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2012 to 2015
$1.9M
Regulation of noncoding RNA biogenesis and functionR00GM104166 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI WILUSZ, JEREMY E · 2014 to 2016
$735k
The Role of microRNAs in Modulating Innate Immunity Signaling and Gut HomeostasisR21AI105797 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ZHOU, RUI · 2014 to 2015
$536k
NIAID NIH HHS R01 AI074951NIAID NIH HHS R01 AI095500NIAID NIH HHS R21 AI105797NIAID NIH HHS T32 AI007324NIAID NIH HHS U54 AI057168NIGMS NIH HHS R00 GM104166
6 · The paper itself

Abstract

RNA degradation is tightly regulated to selectively target aberrant RNAs, including viral RNA, but this regulation is incompletely understood. Through RNAi screening in Drosophila cells, we identified the 3'-to-5' RNA exosome and two components of the exosome cofactor TRAMP (Trf4/5-Air1/2-Mtr4 polyadenylation) complex, dMtr4 and dZcchc7, as antiviral against a panel of RNA viruses. We extended our studies to human orthologs and found that the exosome as well as TRAMP components hMTR4 and hZCCHC7 are antiviral. While hMTR4 and hZCCHC7 are normally nuclear, infection by cytoplasmic RNA viruses induces their export, forming a cytoplasmic complex that specifically recognizes and induces degradation of viral mRNAs. Furthermore, the 3' untranslated region (UTR) of bunyaviral mRNA is sufficient to confer virus-induced exosomal degradation. Altogether, our results reveal that signals from viral infection repurpose TRAMP components to a cytoplasmic surveillance role where they selectively engage viral RNAs for degradation to restrict a broad range of viruses.

Indexed as

AnimalsCell LineCytoplasmDrosophilaExosomesHumansMultiprotein ComplexesPolyadenylationProtein BindingProtein TransportRNA InterferenceRNA StabilityRNA, ViralRNA VirusesRNA Virus InfectionsTranscription FactorsMultiprotein ComplexesRNA, ViralTranscription Factorsantiviralarbovirusexosomeintrinsic immunityRNA degradationTRAMP

Identifiers

PMID27474443
PMCPMC4973295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.